The company’s most recent research and development focus continues to be on readying a line of cannabis-based products targeting Alzheimer’s disease.
Marijuana Industry
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Supplements Popular Beverage with Legal CBD
Lexaria is poised to revolutionize the age-old ritual of afternoon tea.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Enters the Multibillion-Dollar Tea Market
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed delivery technologies to improve absorption of bioactive compounds and intends to use that technology in the tea market.
Cannabis Biotechs Could be Big Pharma’s Latest M&A Focus
InMed’s promising biosynthesis platform could put it on the radar of some major names seeking entry into one the pharmaceutical industry’s fastest-growing sectors.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Wins in Vegas!
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) had a full team at its exhibit, which attracted a lot of attention.
Medical Cannabis Payment Solutions is “One to Watch”
Medical Cannabis Payment Solutions (OTC: REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry.
CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Achieves 42% Month-Over-Month Revenue Growth in October
PotNetwork Holding (OTC: POTN) this morning announced that Diamond CBD, Inc., the company’s wholly owned subsidiary, reported revenues for October of nearly $1.7 million.
Skinvisible, Inc. (SKVI) Targets Global Skincare Market Projected to Reach $135B by 2021
Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market projected to reach $135 billion by 2021.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Presenting at Cannabis-Based Science & Medicine Conference
InMed Pharmaceuticals this morning said that it will be presenting twice at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference.
AppSwarm, Inc. (SWRM) Leverages Technology and Business Expertise to Enter the Cannabis Market Through SinglePoint, Inc. (SING) Joint Venture
AppSwarm, Inc. (OTC: SWRM) has four key revenue streams and is using its business and technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING).
As Bitcoin Boom Continues, Major Players are Validating Promising Forecasts for its Limitless Value Potential
SinglePoint is very close to launching its own bitcoin exchange aimed at solving the current problems of unbankability for cannabis businesses in the United States.
Coming Cannabis Recreational Demand in Canada Triggers Massive Investment
The Canadian government’s commitment to legalize recreational cannabis in July 2018 is touted as an opportunity for investors to profit from the ongoing green blitz.
Skinvisible, Inc.’s (SKVI) Invisicare Technology Tackles Dermatology, CBD Markets
Research and development company Skinvisible, Inc. (OTCQB: SKVI) has developed Invisicare® technology, a patented polymer delivery system that improves the delivery of topically applied skin care products by enhancing the effectiveness of the active ingredients.
Leaders in Medical Marijuana and the Global Alzheimer’s Markets
Investors interested in medicinal marijuana and/or Alzheimer’s treatments will find themselves looking at a global landscape of key players.
Skinvisible, Inc.’s (SKVI) Topical Drug Delivery System Set to Enjoy New Licensing Opportunities
Skinvisible, Inc. (OTCQB: SKVI) is set for a business renaissance in the coming years.